50-State Sterile Compounding
Pharmacy for Sale
Acquire a purpose-built, NABP Verified Pharmacy engineered for telehealth scale. We deliver the infrastructure, the staff, and the licenses—you own the margin.
The Professional Builder Model
Acquire Infrastructure Built by Experts.
PharmaCore offers production-ready facilities, validated and licensed, on a predictable timeline—so you can move directly to improved margins, bypassing M&A, construction, remodeling, and retraining.
Validated Blueprints
We deploy USP <797> and <795> engineered layouts that have already passed the hardest regulatory hurdles. We don't experiment with your build—we execute a proven model.
Turnkey Workforce
Every facility is delivered with a factory-ready team, recruited and trained in KPI-driven SOPs. You're not buying an empty shell—you're acquiring an operational culture.
Fixed-Path Licensing
Our regulatory architecture turns multi-state licensure into defined milestones, not open-ended uncertainty.
The Alternative:
Building from scratch means acting as your own general contractor through a multi-year regulatory and engineering gauntlet. Remodeling a tired facility often exposes legacy constraints that cap scale. PharmaCore eliminates the amateur tax and the remodeling risk.
Our Competitive Advantage
Engineered for Throughput. Built for Exit.
We treat pharmacy infrastructure as a high-precision manufacturing asset. Our "Operational Moat" is built on three interlocking disciplines that maximize facility value.
Engineering
Lowers the Floor
We lower the COGS floor by engineering the facility for maximum throughput and pre-negotiating enterprise-level supply contracts.
Operations
Raises the Ceiling
We raise the capacity ceiling with KPI-driven workflows designed by multi-state licensed operators.
Regulatory
Builds the Moat
We build a regulatory moat around your asset with institutional-grade due diligence, ensuring your facility meets the standards required for Private Equity acquisition.
The Validation
A Proven Asset Class.
Validated Valuation
Our model was proven by a successful exit event at a valuation double our current turnkey pricing after just one year of operation.
Immediate Traction
The operating unit demonstrated immediate profitability through high-margin wellness and GLP-1 compounding.
Market Demand
We validated the exit path with multiple backup buyers in the queue, proving this infrastructure is a highly liquid, institutional-grade asset.
Current Opportunities
We are now accepting inquiries. Whether you are a telehealth brand or multi-location clinic ready to own your margin, or a strategic partner seeking asset-backed infrastructure, we have a validated path forward.
Ready to own your margin?
Connect with our team for facility specifications, formulary fit analysis, or strategic partnership discussions.